The Oncology Institute, Inc.TOINASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+65.0%
5Y CAGR+4.5%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+65.0%/yr
Quarterly compound
5Y CAGR
+4.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 116.42% |
| Q3 2025 | -15.99% |
| Q2 2025 | -114.64% |
| Q1 2025 | -318.68% |
| Q4 2024 | 99.10% |
| Q3 2024 | 106.98% |
| Q2 2024 | -6.02% |
| Q1 2024 | -246.93% |
| Q4 2023 | 48.55% |
| Q3 2023 | 3.72% |
| Q2 2023 | 44.50% |
| Q1 2023 | -8.12% |
| Q4 2022 | 25.93% |
| Q3 2022 | -84.19% |
| Q2 2022 | 34.82% |
| Q1 2022 | 25.71% |
| Q4 2021 | -567.02% |
| Q3 2021 | 53.10% |
| Q2 2021 | -4891.61% |
| Q1 2021 | 16.24% |
| Q4 2020 | 93.59% |
| Q3 2020 | 53.97% |
| Q2 2020 | -21708.25% |
| Q1 2020 | 0.00% |
| Q4 2018 | 0.00% |